Advertisement

Nicotinic and Muscarinic Regulation of Adrenal Catecholamine Secretion

  • Arun R. Wakade
Part of the Advances in Behavioral Biology book series (ABBI, volume 31)

Abstract

The adrenal medulla has served as a very useful experimental tool to investigate a wide variety of noradrenergic mechanisms. The adrenal medulla is innervated by splanchnic neurons originating in the spinal cord, and about three synaptic contacts are made by splanchnic nerve endings on one chromaffin cell (1). Splanchnic neurons have been regarded as predominantly cholinergic in nature and contain acetylcholine as a principal neurotransmitter (2). The well-known sequence of events is that an increase in the activity of presynaptic splanchnic nerves causes the release of acetylcholine which, in turn, activates postsynaptic cholinergic receptors to trigger the secretion of medullary hormones.

Keywords

Adrenal Gland Muscarine Receptor Chromaffin Cell Phorbol Ester Adrenal Medulla 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Coupland, R: Electron microscopic observations on the structure of the rat adrenal medulla. J. Anat. 99:231–254, 1965.PubMedGoogle Scholar
  2. 2.
    Feldberg, W. Minz, B and Tsudzimura, H: The mechanism of the nervous discharge of adrenaline. J. Physiol. 81:286–304, 1934.PubMedGoogle Scholar
  3. 3.
    Douglas, WW: Secretomotor control of adrenal medullary secretion: synaptic, membrane, and ionic events in stimulus-secretion coupling. In (eds.) Creep, RO and Astwood, EB, Handbook of Physiology: Endocrinology, pp. 367–388, 1975.Google Scholar
  4. 4.
    Guidotti, A and Costa, E: A role for nicotinic receptors in the regulation of the adenylate cyclase of adrenal medulla. J. Pharmac. Exp. Ther. 189:665–675, 1974.Google Scholar
  5. 5.
    Wilson, SP and Kirshner, N: The acetylcholine receptor of the adrenal medulla. J. Neurochem. 28:687–695, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Douglas, WW and Poisner, AM: Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine. Nature 208:1102–1103, 1965.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee, FL and Trendelenburg, U: Muscarinic transmission of preganglionic impulses to the adrenal medulla of the cat. J. Pharmac. Exp. Ther. 158:73–79, 1967.Google Scholar
  8. 8.
    Wakade, AR and Wakade, TD: Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine. Neuroscience 10:973–978, 1983.PubMedCrossRefGoogle Scholar
  9. 9.
    Role, LW and Perlman, RL: Both nicotinic and muscarinic receptors mediate catecholamine secretion by isolated guinea-pig chromaffin cells. Neuroscience 10:979–985, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Anton, AH and Sayre, DF: A study of the factors affecting the alumina oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmac. Exp. Ther. 138:360–375, 1962.Google Scholar
  11. 11.
    Kissinger, PT: Amperometric and coulometric detectors for high-performance liquid chromatography. Analyt. Chem. 49:447A–456A, 1977.CrossRefGoogle Scholar
  12. 12.
    Hagen, P: The storage and release of catecholamines. Pharmac. Rev. 11:361–373, 1959.Google Scholar
  13. 13.
    Mirkin, B: Factors influencing the selective secretion of adrenal medullary hormones. J. Pharmac. Exp. Ther. 132:218–225, 1961.Google Scholar
  14. 14.
    Rubin, RP and Miele, E: A study of the differential secretion of epinephrine and norepinephrine from the perfused cat adrenal gland. J. Pharmac. Exp. Ther. 164:115–121, 1968.Google Scholar
  15. 15.
    Silver, M.: The output of adrenaline and noradrenaline from the adrenal medulla of the calf. J. Physiol. 152:14–29, 1960.PubMedGoogle Scholar
  16. 16.
    Caulfield, MP and Straughan, DW: Muscarinic receptors revisited. Trends Neurosci. 6:73–75, 1983.CrossRefGoogle Scholar
  17. 17.
    Birdsall, NJM and Hulme, EC: Muscarinic receptor subclass. Trends. Pharmacol. Sci. 4:459–463, 1983.CrossRefGoogle Scholar
  18. 18.
    Hammer R, Berrie, CP, Birdsall, NJM, Burgen ASV and Hulme, EC: Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–92, 1980.PubMedCrossRefGoogle Scholar
  19. 19.
    Hammer, R: Subclasses of muscarinic receptors and pirenzepine. Further experimental evidence. Scand. J. Gastroenterol. 17, Suppl. 72:59–67, 1982.Google Scholar
  20. 20.
    Roszkowski, AP: An unusual type of sympathetic ganglionic stimulant. J. Pharmac. Exp. Ther. 132:156–170, 1961.Google Scholar
  21. 21.
    Hammer, R and Giachetti, A: Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 31:2991–2998, 1982.PubMedCrossRefGoogle Scholar
  22. 22.
    Douglas, WW: Stimulus-secretion coupling: The concept and clues from chromaffin and other cells. Br. J. Pharmac. 34:453–474, 1968.Google Scholar
  23. 23.
    Rubin, RP: The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol. Rev. 22:389–428, 1970.PubMedGoogle Scholar
  24. 24.
    Douglas, WW and Rubin, RP: The role of calcium in the secretory response of the adrenal medulla to acetylcholine. J. Physiol. 159:40–57, 1961.PubMedGoogle Scholar
  25. 25.
    Nestler, EJ, Walaas, S. I. and Greengard, P: Neuronal phosphoproteins: physiological and clinical implications. Science 225:1357–1364, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Nishizuka, Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693–698, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Castagna, M, Takai, Y, Kaibuchi, K Sano, K., Kikkawa, U and Nishizuka, Y: Direct activation of calcium-activated, phospholipid dependent protein kinase by tumor promoting phorbol esters. J. Biol. Chem. 257:7847–7851, 1982.PubMedGoogle Scholar
  28. 28.
    Niedel, JE, Kuhn, LJ and Vandenbark, GR: Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA 80:36–40, 1983.PubMedCrossRefGoogle Scholar
  29. 29.
    Seamon, KB, Padgett, W and Daly, JW: Forskolin: unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc. Natl. Acad. Sci USA 78:3363–3367, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Daly, JW, Padgett, W, and Seamon, KB: Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: augmentation of receptor mediated responses. J. Neurochem. 38:532–544, 1982.PubMedCrossRefGoogle Scholar
  31. 31.
    Wakade, AR: Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J. Physiol. 313:463–480, 1981.PubMedGoogle Scholar
  32. 32.
    Wakade, A.R., Malhotra, R.K., and Wakade, T.D. Phorbol ester facilitates 45Ca accumulation and catecholamine secretion by nicotine and excess K, but not by muscarine in rat adrenal medulla. Nature 321:698–700, 1986.PubMedCrossRefGoogle Scholar
  33. 33.
    Wakade, A.R., Kahn, R., Malhotra, R.K., Wakade, C. and Wakade, T.D. McN-A-343, a specific agonist of M, muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla Life Sci. 39:2073–2080, 1986.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Arun R. Wakade
    • 1
  1. 1.Department of PharmacologyState University of New York Downstate Medical CenterBrooklynUSA

Personalised recommendations